Home/Noveome Biotherapeutics/Karin Potoka, MD, FAAP
KP

Karin Potoka, MD, FAAP

Chief Medical Officer

Noveome Biotherapeutics

Noveome Biotherapeutics Pipeline

DrugIndicationPhase
ST266Necrotizing Enterocolitis (NEC) in Premature InfantsPhase 1-2